Frazier Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Frazier Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.3K	Buy	896 +674	+304%	+$39.3K	0.03%	176
2025 Q4	$12K	Buy	222 +69	+45%	+$3.32K	0.01%	333
2025 Q3	$6.9K	Hold	153	–	–	﹤0.01%	411
2025 Q2	$7.08K	Sell	153 -332	-68%	-$16.3K	0.01%	405
2025 Q1	$29.6K	Sell	485 -209	-30%	-$12.2K	0.02%	199
2024 Q4	$38.9K	Buy	694 +332	+92%	+$18.6K	0.03%	158
2024 Q3	$18.7K	Sell	362 -255	-41%	-$12K	0.01%	267
2024 Q2	$25.6K	Sell	617 -228	-27%	-$10.2K	0.02%	248
2024 Q1	$45.8K	Sell	845 -66	-7%	-$3.36K	0.04%	160
2023 Q4	$46.7K	Buy	+911	New	+$47.8K	0.04%	143

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frazier Financial Advisors's BMY Position: Q1 2026 in Review

Frazier Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 304% in Q1 2026, buying an estimated $39.3K and bringing the position to 896 shares worth $54.3K. The position accounts for 0.03% of the portfolio, ranked #176.

Frazier Financial Advisors first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Frazier Financial Advisors held 896 shares of Bristol-Myers Squibb worth $54.3K as of Q1 2026.
Frazier Financial Advisors bought 674 Bristol-Myers Squibb shares in Q1 2026, an estimated $39.3K.
Bristol-Myers Squibb made up 0.03% of Frazier Financial Advisors's portfolio in Q1 2026, its #176 holding.
Frazier Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.